Skip to product information
1 of 1

SAMD9 Recombinant Rabbit mAb (S-4324-1)

SAMD9 Recombinant Rabbit mAb (S-4324-1)

Catalog Number: S0B60823 Application: WB Reactivity: Hu Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rabbit
Antigen SAMD9
Synonyms Sterile alpha motif domain-containing protein 9; C7orf5; DRIF1; KIAA2004; OEF1
Immunogen Recombinant Protein
Location Cytoplasm
Accession Q5K651
Clone Number S-4324-1
Antibody Type Recombinant mAb
Isotype IgG
Application WB
Reactivity Hu
Positive Sample A-431, BxPC-3, SK-OV-3, HeLa
Purification Protein A
Concentration 2 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.02% sodium azide

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
WB 1:1000 Hu

Background

SAMD9 (sterile alpha motif domain-containing protein 9) is a widely expressed cytoplasmic multidomain protein that combines antiviral defense, translational repression, and regulation of cell proliferation. Through its effector domain, it preferentially binds double-stranded nucleic acids and specifically cleaves phenylalanine tRNA, thereby suppressing global protein translation, while also playing a key role in antiviral granule formation and innate immune responses. SAMD9 expression is induced by interferon and TNF-α, and upon activation it downregulates MYC and E2F target genes, thereby inhibiting cell proliferation. Structurally, SAMD9 exists predominantly in a closed, autoinhibited conformation stabilized by an ATP-bound NOD module and extensive intramolecular interactions; pathogenic gain-of-function mutations disrupt these autoinhibitory interfaces, leading to aberrant protein activation. Clinically, biallelic loss-of-function mutations in SAMD9 cause normophosphatemic familial tumoral calcinosis, whereas heterozygous gain-of-function mutations cause MIRAGE syndrome (myelodysplasia, infection, restriction of growth, adrenal hypoplasia, genital phenotypes, and enteropathy) and predispose to monosomy 7 myelodysplastic syndrome and leukemia.

Picture

Western Blot

WB result of SAMD9 Recombinant Rabbit mAb
Primary antibody: SAMD9 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: Raji whole cell lysate 20 μg
Lane 2: MCF7 whole cell lysate 20 μg
Lane 3: A-431 whole cell lysate 20 μg
Lane 4: BxPC-3 whole cell lysate 20 μg
Lane 5: SK-OV-3 whole cell lysate 20 μg
Lane 6: HeLa whole cell lysate 20 μg
Negative control: Raji whole cell lysate; MCF7 whole cell lysate
Secondary antibody: Goat Anti-Rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 185 kDa
Observed MW: 185 kDa